Clinical Trial Detail

NCT ID NCT03224871
Title A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Aldesleukin

Nivolumab

Age Groups: adult senior

No variant requirements are available.